AUSTIN, TX – Tekton Research, a clinical research company focusing on clinical trials for pharmaceuticals and device companies, is excited to welcome Jason Roth back to the Tekton family. Jason will serve as the Chief Business Officer (CBO), overseeing business development, client relationships, and feasibility activities. One of his primary focus areas will be the expansion of Tekton’s capabilities including site and investigator growth.
Kip McKenzie, CEO of Tekton Research, is thrilled to have Jason back full-time. “We are very excited to have Jason Roth rejoin Tekton Research as our CBO. Jason first joined Tekton in 2010 and most recently served as VP of Business Development for Platinum Research Network. Over the last few years, Tekton has experienced significant growth and Jason is filling a key role that will help us develop and expand our sites. Welcome Home Jason!”, said Kip.
With over 20 years of clinical research experience, Jason brings a depth of knowledge and a wide range of experience. “This is a homecoming for me. I’ve supported business development for Tekton in various roles over the last decade”, said Jason. “I’m ecstatic to rejoin the team and help expand into new markets.”
Along with Tekton’s greater business development team, Jason will attend the SCRS Global Site Solutions Summit in Hollywood, FL, and the World Vaccine Congress in Barcelona, Spain in October. “I look forward to connecting with our strategic partners at SCRS, along with our vaccine colleagues in Barcelona”, Jason said.
For more information or to request a meeting, contact [email protected].
